Guilin Sanjin Pharmaceutical Co Ltd (002275) — Cash Flow-to-Debt Ratio
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥117.62 Million could theoretically repay 0% of its total liabilities (CN¥1.05 Billion) in one year. See Guilin Sanjin Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guilin Sanjin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Guilin Sanjin Pharmaceutical Co Ltd.
Annual Cash Flow-to-Debt Ratio for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Guilin Sanjin Pharmaceutical Co Ltd. Check Guilin Sanjin Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | CN¥588.33 Million | CN¥1.22 Billion | ▼ -1.9% |
| 2023 | 0.49x | CN¥549.25 Million | CN¥1.12 Billion | ▲ +6.9% |
| 2022 | 0.46x | CN¥528.67 Million | CN¥1.15 Billion | ▲ +40.6% |
| 2021 | 0.33x | CN¥410.24 Million | CN¥1.26 Billion | ▼ -49.6% |
| 2020 | 0.65x | CN¥597.99 Million | CN¥923.27 Million | ▼ -17.0% |
| 2019 | 0.78x | CN¥468.29 Million | CN¥600.18 Million | ▼ -15.2% |
| 2018 | 0.92x | CN¥551.73 Million | CN¥599.47 Million | ▲ +36.6% |
| 2017 | 0.67x | CN¥387.82 Million | CN¥575.65 Million | ▼ -44.2% |
| 2016 | 1.21x | CN¥536.85 Million | CN¥444.26 Million | ▲ +26.3% |
| 2015 | 0.96x | CN¥398.50 Million | CN¥416.59 Million | ▲ +11.7% |
| 2014 | 0.86x | CN¥396.53 Million | CN¥463.07 Million | ▲ +32.5% |
| 2013 | 0.65x | CN¥314.16 Million | CN¥486.11 Million | ▼ -13.0% |
| 2012 | 0.74x | CN¥302.59 Million | CN¥407.26 Million | ▼ -52.5% |
| 2011 | 1.56x | CN¥341.05 Million | CN¥218.18 Million | ▼ -0.6% |
| 2010 | 1.57x | CN¥285.49 Million | CN¥181.47 Million | ▲ +20.8% |
| 2009 | 1.30x | CN¥363.29 Million | CN¥279.00 Million | ▲ +158.2% |
| 2008 | 0.50x | CN¥190.97 Million | CN¥378.65 Million | ▲ +7.2% |
| 2007 | 0.47x | CN¥164.39 Million | CN¥349.58 Million | ▼ -55.8% |
| 2006 | 1.06x | CN¥217.67 Million | CN¥204.48 Million | — |